Unicorn Nest Logo

HLM Venture Partners

www.hlmvp.com
Total investments

139

Average round size

19M

Portfolio companies

79

Rounds per year

3.39

Lead investments

8

Follow on index

0.43

Exits

40

Stages of investment
Early Stage VentureLate Stage Venture
Areas of investment
BiotechnologySoftwareInformation TechnologyHealth CareHospitalEnterprise SoftwareMedical DeviceMedicalPharmaceuticalmHealth

Investments analytics

Analytics

Total investments
139
Lead investments
8
Exits
40
Rounds per year
3.39
Follow on index
0.43
Investments by industry
  • Health Care (111)
  • Medical (38)
  • Information Technology (36)
  • Software (31)
  • Hospital (23)
    • Show 71 more
Investments by region
  • United States (134)
  • Canada (3)
  • India (1)
  • Denmark (1)
Peak activity year
2006
Number of Unicorns
2
Number of Decacorns
3

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.
Sign Up

Quantitative data

Avg. startup age at the time of investment
17
Avg. valuation at time of investment
293M
Group Appearance index
0.88
Avg. company exit year
14
Avg. multiplicator
8.54
Strategy success index
0.90

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Upgrade

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Regroup Therapy 15 Jun 2017 Health Care, Psychology, Outpatient Care Early Stage Venture 6M United States, Illinois, Chicago
Yuvo Health 07 Jun 2023 Health Care, Communities, Medical Early Stage Venture 20M United States, New York, New York
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.